Antibiotics During Intrauterine Balloon Tamponade Placement

• Status: Terminated
• Trial end date: 2021-05-03
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this study is to identify whether antibiotics given at the time of placement of an intrauterine balloon tamponade (IBT) will result in reduction of the risk of endometritis. The investigators hypothesize that antibiotics given at the time of intrauterine balloon tamponade will reduce the likelihood of postpartum endometritis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cedars-Sinai Medical Center
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cefazolin; Clindamycin; Clindamycin palmitate; Clindamycin phosphate

Criteria

Inclusion Criteria:

• Female

• Able to give consent

• Gestational age > 24 weeks

• Postpartum

• Placement of an IBT within the last 2 hours with plans for it to remain in situ for at least 2 hours

• Primary obstetrician amenable to proceeding with either method of management during the study period.

Exclusion Criteria:

• Age < 18 years old

• IBT removed within 2 hours of placement

• Chorioamnionitis

• Insufficient documentation of demographics, delivery outcomes, or peripartum events including postpartum hemorrhage, infectious outcomes